Absorption, metabolism, and excretion of oral ¹⁴C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men

MLA

Ellen, Scheers, et al. “Absorption, Metabolism, and Excretion of Oral ¹⁴C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 43, no. 2, Dec. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aad7c53b5e2b4abc196f57d90d83c0a2&authtype=sso&custid=ns315887.

APA

Ellen, S., Laurent, L., Jan, de J., Nini, B., Marc, B., Aline, L., Filip, C., Donna, S., Joe, M., Juthamas, S., & Geert, M. (2014). Absorption, metabolism, and excretion of oral ¹⁴C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 43(2).

Chicago

Ellen, Scheers, Leclercq Laurent, de Jong Jan, Bode Nini, Bockx Marc, Laenen Aline, Cuyckens Filip, et al. 2014. “Absorption, Metabolism, and Excretion of Oral ¹⁴C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 43 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aad7c53b5e2b4abc196f57d90d83c0a2&authtype=sso&custid=ns315887.